We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
203 hedge funds and large institutions have $2.88B invested in Denali Therapeutics in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 84 increasing their positions, 60 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
119% more call options, than puts
Call options by funds: $4.24M | Put options by funds: $1.93M
40% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 60
15% more capital invested
Capital invested by funds: $2.51B → $2.88B (+$365M)
1.08% less ownership
Funds ownership: 87.96% → 86.88% (-1.1%)
3% less funds holding
Funds holding: 210 → 203 (-7)
15% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 34
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
203
Holders Change
-7
Holders Change %
-3.33%
% of All Funds
2.93%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
29
Increased
84
Reduced
60
Closed
34
Calls
$4.24M
Puts
$1.93M
Net Calls
+$2.3M
Net Calls Change
+$2.26M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$36.1M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$30.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.8M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$20.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.2M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$36.3M |
| 2 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$28M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$24.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.2M |
| 5 |
Holocene Advisors
New York
|
-$15.4M |
